Risks of antipsychotic use in dementia extend beyond previous alerts, study shows
Antipsychotic use in people with dementia is associated with higher risks of a wide range of serious health outcomes compared with non-use, according to a
Antipsychotic use in people with dementia is associated with higher risks of a wide range of serious health outcomes compared with non-use, according to a
The FDA has set a target date of 15 September 2024, four months ahead of the normal review schedule as per priority review benefits. Image
The airline industry is often held up as a model of operational excellence — one that the health care industry would do well to emulate.